Product
Sodium Pentaborate
1 clinical trial
1 indication
Indication
Renal Cell CarcinomaClinical trial
Evaluation of the Safety and Efficacy of Sodium Pentaborate Pentahydrate in Patients With Advanced Renal Cell Carcinoma: An Open-label Single-arm Phase 1b/2 TrialStatus: Not yet recruiting, Estimated PCD: 2025-05-22